Nuo Therapeutics, Inc.

About Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.

Nuo Therapeutics is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing.

AURX United States

3.35USD0.6 (+17.91%)

• At close Fri Oct 07 2022

Other OTC exchange

Sector: Healthcare

Industry: Biotechnology

Location United States, Houston

Grade: AEF

63,534,480 USD
BETA (5y)


for 5 years
for 3 years
for 2 years
for last year
for this year
Nuo Therapeutics, Inc.
© 2024 All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.